Demant Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Make Smarter Decisions with the Full Value Chain Report
This Demant Value Chain Analysis gives you a clear, company-specific view of how Demant creates value across support and primary activities. What you see on this page is a real preview of the actual analysis, so you can review the format and substance before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Demant A/S runs firm infrastructure through centralized governance, finance, legal, and quality systems, which helps keep control across hearing aids, hearing implants, diagnostics, and communication solutions. This setup matters in a regulated medtech market because it supports compliance, faster decision-making, and tighter cost control.
In 2025, this structure helped Demant A/S protect margins while coordinating global operations and product oversight. One clean point: in medtech, strong back-office control is part of the moat.
Human Resource Management
Demant A/S's human resource management relies on audiologists, engineers, software developers, and manufacturing specialists to keep its hearing-care and device business moving. In its 2025 reporting, Demant A/S shows that this talent base supports product innovation, clinical service quality, and steady execution across retail and professional channels. Hiring and retaining these roles matters because the work spans research, software, fitting, and factory output, so each skill gap can hit both growth and service levels.
Technology Development
Technology development is a key edge for Demant A/S because hearing care depends on acoustics, connectivity, software, and implant performance. In 2025, Demant kept R&D spend at about DKK 1.5 billion, or roughly 7% of revenue, which supports better sound processing, fitting tools, and digital services. This helps Demant A/S defend premium pricing and keep product cycles tight.
Procurement
Demant A/S sources precision components, electronics, acoustic parts, and medical-grade materials from specialized suppliers, so procurement is central to product quality and compliance. In 2025, tight supplier control helped protect traceability across regulated hearing and diagnostic devices, where every part must match spec. Strong buying discipline also limits scrap, delays, and rework, which matters when production depends on clean, repeatable inputs. It is a control point, not just a cost line.
Demant's 2025 support engine: tight controls, talent, and DKK 1.5B R&D
Demant A/S's support activities in 2025 were built to back regulated, global hearing-care operations: firm infrastructure kept governance, finance, legal, and quality tight; HR supported scarce audiology and engineering talent; and R&D stayed near DKK 1.5 billion, or about 7% of revenue.
| Support activity | 2025 data |
|---|---|
| R&D | DKK 1.5 billion |
| R&D intensity | About 7% of revenue |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Demant A/S depends on qualified suppliers for microelectronics, acoustic parts, implant materials, and packaging, so inbound logistics starts with strict sourcing control. Small defects can hit device performance and regulatory compliance, which makes traceability and incoming quality checks essential. In 2025, this matters even more for a business with DKK 22.7 billion in revenue, because one bad batch can disrupt high-value hearing and implant production.
Operations
In fiscal 2025, Demant A/S operations converted hearing aids, hearing implants, diagnostic equipment, and communication tools into regulated medical devices, with software calibration and device settings tuned for clinical use.
This stage depends on tight quality control, traceability, and documentation because each unit must meet medical device rules before release. Demant A/S also supports a global base of clinics and users across 130+ countries.
Operations are a core cost and margin driver, since yield, rework, and compliance work shape how much value Demant A/S keeps from each finished device.
Outbound Logistics
In 2025, Demant A/S used outbound logistics to move devices and systems to 4 channels: clinics, hospitals, distributors, and its own hearing-care network. Fast delivery keeps fitting visits, stock refill, and after-sales service on time, so fewer patients wait for care.
Reliable shipping also helps Demant A/S cut stock-outs and speed up service turnarounds across markets. In a business built on booked appointments, even a short delay can slow revenue conversion.
Marketing and Sales
Demant A/S sells hearing devices and communication solutions through audiology clinics, clinic networks, and brand-led demand generation. In Marketing and Sales, clinician trust and patient education are key because conversion improves when dealers can show clear hearing gains and fit quality. This channel supports repeat prescription flow and helps protect pricing in a market where service quality drives purchase decisions.
Service
Demant A/S service covers fittings, staff training, repairs, software updates, and after-sales help for hearing care partners and users. This stage keeps devices working well, lowers returns, and supports a better patient fit after the sale. Strong service also helps Demant A/S keep clinics and distributors loyal, which matters in a market where repeat care drives long-term revenue.
Demant's 2025: DKK 22.7B Revenue Across 130+ Countries
In fiscal 2025, Demant A/S primary activities were anchored in operations, with DKK 22.7 billion revenue and a global reach across 130+ countries. Strong inbound quality control, regulated device manufacturing, and traceable assembly matter because small defects can hit hearing aid and implant performance. Outbound delivery and after-sales service then keep clinics supplied and fittings on time.
| 2025 metric | Value |
|---|---|
| Revenue | DKK 22.7bn |
| Geographic reach | 130+ countries |
| Core output | Hearing aids, implants, diagnostics |
What You See Is What You Get
Demant Reference Sources
This preview shows the actual Demant Value Chain Analysis document you'll receive after purchase – no sample content, no surprises.
The full version is the same professional, structured report, with complete details unlocked immediately after checkout.
Buy now to access the entire Demant Value Chain Analysis file in full.
Frequently Asked Questions
Technology development and service matter most. Demant A/S competes on clinical performance, software, and professional support across 3 core product categories, so the highest-value work happens before and after the sale. The chain has 4 support activities and 5 primary activities, but R&D and care drive differentiation and pricing power.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.